Allergy Therapeutics PLC
LSE:AGY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Allergy Therapeutics PLC
LSE:AGY
|
UK |
|
Poste Italiane SpA
OTC:PITAF
|
IT |
|
Banco Pine SA
BOVESPA:PINE4
|
BR |
|
ACS Actividades de Construccion y Servicios SA
F:OCI1
|
ES |
|
B
|
Beiersdorf AG
DUS:BEI
|
DE |
|
Red Violet Inc
NASDAQ:RDVT
|
US |
|
National Vision Holdings Inc
NASDAQ:EYE
|
US |
|
Kingstone Companies Inc
NASDAQ:KINS
|
US |
|
Softronic AB
STO:SOF B
|
SE |
|
J
|
JATT Acquisition Corp
F:1GU
|
KY |
|
Littelfuse Inc
NASDAQ:LFUS
|
US |
|
B
|
BAE Systems PLC
SWB:BSP
|
UK |
|
Doosan Enerbility Co Ltd
KRX:034020
|
KR |
|
Legend Power Systems Inc
XTSX:LPS
|
CA |
|
Blue Hat Interactive Entertainment Technology
F:4Y80
|
CN |
|
Catapult Group International Ltd
ASX:CAT
|
AU |
|
Oceania Healthcare Ltd
ASX:OCA
|
NZ |
|
Wintermar Offshore Marine Tbk PT
IDX:WINS
|
ID |
Shareholder Yield
Current shareholder yield for AGY is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
AGY Price
Allergy Therapeutics PLC
| Average Annual Return | 14.8% |
| Standard Deviation of Annual Returns | 114.77% |
| Max Drawdown | -98% |
| Market Capitalization | 546.6m GBX |
| Shares Outstanding | 6 332 530 000 |
| Percentage of Shares Shorted |
N/A
|
